MANKIND PHARMA
|
MANKIND PHARMA Last 5 Year Income Statement History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹10,677 Cr | ₹910,563 Cr | ₹8,071 Cr | ₹647 Cr | ₹61,007 Cr |
Sales | ₹10,607 Cr | ₹904,838 Cr | ₹8,067 Cr | ₹646 Cr | ₹60,924 Cr |
Job Work/ Contract Receipts | ₹21 Cr | ₹3,421 Cr | - | - | - |
Processing Charges / Service Income | ₹49 Cr | ₹2,304 Cr | ₹3.46 Cr | ₹0.25 Cr | ₹16 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | - | - | - | - | ₹68 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹10,260 Cr | ₹874,943 Cr | ₹7,782 Cr | ₹621 Cr | ₹58,719 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-54 Cr | ₹29,074 Cr | ₹-450 Cr | ₹-25 Cr | ₹-105 Cr |
Raw Material Consumed | ₹3,252 Cr | ₹262,290 Cr | ₹2,871 Cr | ₹203 Cr | ₹18,885 Cr |
Opening Raw Materials | ₹414 Cr | ₹39,862 Cr | ₹284 Cr | ₹25 Cr | ₹1,605 Cr |
Purchases Raw Materials | ₹1,837 Cr | ₹182,940 Cr | ₹2,173 Cr | ₹141 Cr | ₹13,699 Cr |
Closing Raw Materials | ₹409 Cr | ₹41,436 Cr | ₹399 Cr | ₹28 Cr | ₹2,331 Cr |
Other Direct Purchases / Brought in cost | ₹1,410 Cr | ₹80,924 Cr | ₹814 Cr | ₹65 Cr | ₹5,912 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹125 Cr | ₹10,896 Cr | ₹103 Cr | ₹8.25 Cr | ₹800 Cr |
Electricity & Power | ₹125 Cr | ₹10,896 Cr | ₹103 Cr | ₹8.25 Cr | ₹800 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹2,261 Cr | ₹191,847 Cr | ₹1,621 Cr | ₹142 Cr | ₹13,355 Cr |
Salaries, Wages & Bonus | ₹2,094 Cr | ₹178,801 Cr | ₹1,515 Cr | ₹133 Cr | ₹12,714 Cr |
Contributions to EPF & Pension Funds | ₹100 Cr | ₹8,896 Cr | ₹74 Cr | ₹5.87 Cr | ₹429 Cr |
Workmen and Staff Welfare Expenses | ₹19 Cr | ₹2,191 Cr | ₹15 Cr | ₹1.16 Cr | ₹89 Cr |
Other Employees Cost | ₹47 Cr | ₹1,959 Cr | ₹17 Cr | ₹1.54 Cr | ₹123 Cr |
Other Manufacturing Expenses | ₹173 Cr | ₹15,057 Cr | ₹160 Cr | ₹14 Cr | ₹1,092 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹43 Cr | ₹3,887 Cr | ₹37 Cr | ₹2.70 Cr | ₹250 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹130 Cr | ₹11,170 Cr | ₹124 Cr | ₹11 Cr | ₹842 Cr |
General and Administration Expenses | ₹939 Cr | ₹100,080 Cr | ₹656 Cr | ₹45 Cr | ₹4,390 Cr |
Rent , Rates & Taxes | ₹89 Cr | ₹13,196 Cr | ₹84 Cr | ₹5.86 Cr | ₹609 Cr |
Insurance | ₹18 Cr | ₹1,544 Cr | ₹14 Cr | ₹1.04 Cr | ₹84 Cr |
Printing and stationery | ₹9.50 Cr | ₹1,042 Cr | ₹7.02 Cr | ₹0.53 Cr | ₹43 Cr |
Professional and legal fees | ₹203 Cr | ₹16,935 Cr | ₹88 Cr | ₹4.94 Cr | ₹308 Cr |
Traveling and conveyance | ₹378 Cr | ₹49,605 Cr | ₹358 Cr | ₹27 Cr | ₹2,695 Cr |
Other Administration | ₹242 Cr | ₹17,758 Cr | ₹105 Cr | ₹5.77 Cr | ₹651 Cr |
Selling and Distribution Expenses | ₹924 Cr | ₹63,811 Cr | ₹708 Cr | ₹59 Cr | ₹4,267 Cr |
Advertisement & Sales Promotion | ₹601 Cr | ₹37,367 Cr | ₹452 Cr | ₹39 Cr | ₹2,553 Cr |
Sales Commissions & Incentives | ₹198 Cr | ₹18,049 Cr | ₹174 Cr | ₹14 Cr | ₹1,244 Cr |
Freight and Forwarding | ₹125 Cr | ₹8,367 Cr | ₹82 Cr | ₹6.15 Cr | ₹470 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹0.15 Cr | ₹28 Cr | ₹0.22 Cr | ₹0.02 Cr | - |
Miscellaneous Expenses | ₹125 Cr | ₹11,696 Cr | ₹121 Cr | ₹11 Cr | ₹1,587 Cr |
Bad debts /advances written off | ₹4.62 Cr | ₹464 Cr | ₹4.92 Cr | ₹0.06 Cr | ₹6.12 Cr |
Provision for doubtful debts | ₹7.96 Cr | ₹915 Cr | ₹9.65 Cr | ₹0.11 Cr | ₹59 Cr |
Losson disposal of fixed assets(net) | - | - | ₹3.74 Cr | ₹0.30 Cr | - |
Losson foreign exchange fluctuations | - | - | - | - | ₹10 Cr |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹112 Cr | ₹10,317 Cr | ₹103 Cr | ₹10 Cr | ₹1,511 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹7,745 Cr | ₹684,750 Cr | ₹5,791 Cr | ₹457 Cr | ₹44,272 Cr |
Operating Profit (Excl OI) | ₹2,515 Cr | ₹190,193 Cr | ₹1,991 Cr | ₹165 Cr | ₹14,447 Cr |
Other Income | ₹280 Cr | ₹12,857 Cr | ₹196 Cr | ₹17 Cr | ₹1,038 Cr |
Interest Received | ₹40 Cr | ₹1,276 Cr | ₹13 Cr | ₹3.83 Cr | ₹129 Cr |
Dividend Received | - | ₹0.24 Cr | ₹0.00 Cr | ₹0.04 Cr | ₹43 Cr |
Profit on sale of Fixed Assets | ₹0.48 Cr | ₹166 Cr | - | - | ₹19 Cr |
Profits on sale of Investments | - | - | - | - | ₹351 Cr |
Provision Written Back | ₹2.48 Cr | ₹415 Cr | ₹34 Cr | ₹0.77 Cr | - |
Foreign Exchange Gains | ₹8.44 Cr | ₹1,041 Cr | ₹8.85 Cr | ₹0.05 Cr | - |
Others | ₹229 Cr | ₹9,958 Cr | ₹140 Cr | ₹12 Cr | ₹496 Cr |
Operating Profit | ₹2,795 Cr | ₹203,050 Cr | ₹2,187 Cr | ₹182 Cr | ₹15,485 Cr |
Interest | ₹34 Cr | ₹4,576 Cr | ₹60 Cr | ₹2.12 Cr | ₹232 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹19 Cr | ₹3,605 Cr | ₹16 Cr | ₹1.55 Cr | ₹137 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹6.42 Cr | ₹130 Cr | ₹4.02 Cr | ₹0.19 Cr | ₹17 Cr |
Other Interest | ₹8.71 Cr | ₹842 Cr | ₹40 Cr | ₹0.38 Cr | ₹78 Cr |
PBDT | ₹2,761 Cr | ₹198,473 Cr | ₹2,127 Cr | ₹180 Cr | ₹15,253 Cr |
Depreciation | ₹378 Cr | ₹32,592 Cr | ₹167 Cr | ₹12 Cr | ₹991 Cr |
Profit Before Taxation & Exceptional Items | ₹2,383 Cr | ₹165,881 Cr | ₹1,960 Cr | ₹168 Cr | ₹14,262 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹2,398 Cr | ₹167,124 Cr | ₹1,975 Cr | ₹169 Cr | ₹14,377 Cr |
Provision for Tax | ₹457 Cr | ₹36,156 Cr | ₹522 Cr | ₹40 Cr | ₹3,816 Cr |
Current Income Tax | ₹495 Cr | ₹33,199 Cr | ₹451 Cr | ₹39 Cr | ₹4,084 Cr |
Deferred Tax | ₹-31 Cr | ₹4,117 Cr | ₹49 Cr | ₹0.24 Cr | ₹-327 Cr |
Other taxes | ₹-7.22 Cr | ₹-1,160 Cr | ₹21 Cr | ₹0.14 Cr | ₹59 Cr |
Profit After Tax | ₹1,941 Cr | ₹130,968 Cr | ₹1,453 Cr | ₹129 Cr | ₹10,561 Cr |
Extra items | ₹0.98 Cr | - | - | - | - |
Minority Interest | ₹-29 Cr | ₹-2,782 Cr | ₹-19 Cr | ₹-2.76 Cr | ₹-257 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹1,913 Cr | ₹128,186 Cr | ₹1,433 Cr | ₹127 Cr | ₹10,304 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹8,012 Cr | ₹673,519 Cr | ₹5,304 Cr | ₹407 Cr | ₹34,076 Cr |
Appropriations | ₹9,925 Cr | ₹801,705 Cr | ₹6,737 Cr | ₹533 Cr | ₹44,380 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹6.27 Cr | ₹485 Cr | ₹1.80 Cr | ₹2.74 Cr | ₹2,484 Cr |
Equity Dividend % | - | - | - | - | ₹310.00 |
Earnings Per Share | ₹47.75 | ₹32.00 | ₹35.78 | ₹31.59 | ₹25.72 |
Adjusted EPS | ₹47.75 | ₹32.00 | ₹35.78 | ₹31.59 | ₹25.72 |
Compare Income Statement of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹105,746.1 Cr | 0.8% | 8.4% | 26.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 0.8% |
8.4% |
26.4% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses